课题基金 / 基金详情

Development and Applications of Bioorthogonal Chemistry: Administrative Supplement for Equipment

Development and Applications of Bioorthogonal Chemistry: Administrative Supplement for Equipment
生物正交化学的发展与应用:设备管理补充
批准号:
10581256
负责人:
Qing Lin
金额:
$7.44万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-01 至 2023-12-31

项目摘要

项目成果

Qing Lin的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Development and Applications of Bioorthogonal Chemistry: Administrative Supplement for Equipment ABSTRACT We have a long-standing interest in developing reactivity-based chemical tools to address significant biological problems that are difficult to solve using conventional molecular biology techniques. In our MIRA application, we plan to continue our studies of orthogonal chemical reactivity at the chemistry-biology interface and pursue the following two related projects. In Project 1, we will construct the FRET-based biosensors of GLP-1R and GCGR using bioorthogonal chemistry techniques. These biosensors will then be employed to probe the conformational dynamics during the ligand-induced receptor activation and signaling in live cells. A new set of fluorescence 'turn-on' reagents will be designed for bioorthogonal labeling of the intracellular loop 3 of GLP-1R and GCGR to allow single-cell intra- and inter-molecular FRET analysis of receptor dynamics in live cells. In Project 2, we will develop a genetically encoded chemical crosslinker containing an alkyne group and apply this chemical crosslinker to map the time-dependent GLP-1R and -arrestins interactomes by mass spectrometry in response to ligand stimulation. We expect these studies to validate new bioorthogonal tools for real-time monitoring of protein conformation and protein-protein interactions in live cells. Also, we will gain novel insights into the GLP-1R and GCGR activation dynamics and structural basis of biased signaling that are crucial for the development of targeted therapies for the treatment of diabetes and obesity. This Administrative Supplement requests the acquisition of an Agilent 1260 Infinity II LC System with Diode Array Detector. This system will help us characterize the bioorthogonal reagents' reaction kinetics and selectivity at higher throughput and greater accuracy.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Orthogonal Crosslinking: A Strategy to Generate Novel Protein Topology and Function.
正交交联:生成新型蛋白质拓扑和功能的策略。
DOI: 10.1002/chem.202202828
发表时间: 2023
期刊: Chemistry (Weinheim an der Bergstrasse, Germany)
影响因子: --
作者: [Wang,Zheng, Rabb,JohnathanD, Lin,Qing]
通讯作者: Lin,Qing
DOI: 10.1016/j.bmc.2021.116256
发表时间: 2021-08-01
期刊: Bioorganic & medicinal chemistry
影响因子: 3.5
作者: [Tian Y, Fang M, Lin Q]
通讯作者: Lin Q
DOI: 10.1002/anie.202202657
发表时间: 2022-05-23
期刊: ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
影响因子: 16.6
作者: [Xu, Yali, Rahim, Abdur, Lin, Qing]
通讯作者: Lin, Qing
Systematic Structural Tuning Yields Hydrazonyl Sultones for Faster Bioorthogonal Protein Modification.
系统的结构调整产生腙磺内酯,用于更快的生物正交蛋白质修饰。
DOI: 10.1002/cbic.202300398
发表时间: 2023
期刊: Chembiochem : a European journal of chemical biology
影响因子: --
作者: [Fang,Ming, SrikanthKumar,Gangam, Lin,Qing]
通讯作者: Lin,Qing
11
    Development of Orally Administered Peptide Hormones for Treatment of Diabetes and Obesity
    • 批准号:
      10323876
    • 项目类别:
    • 资助金额:
      $30.0万
    • 财政年份:
      2021
    • 负责人:
      Qing Lin
    • 依托单位:
    Development and Applications of Bioorthogonal Chemistry
    Development and Applications of Bioorthogonal Chemistry
    Development and Applications of Photoinducible Bioorthogonal Chemistry
    海外基金